Align Technology Inc

Most Recent

  • uploads///recommendations
    Company & Industry Overviews

    What Wall Street Analysts Recommend for Dentsply Sirona

    Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years.

    By Sarah Collins
  • uploads///kyle sterk  unsplash
    Company & Industry Overviews

    ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain

    On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Align Technology Traded at Its 52-Week High in September

    Align Technology was trading at its 52-week high of $398.88 on September 25. The stock reported its 52-week low of $180.31 on September 28, 2017.

    By Sarah Collins
  • uploads///recommendation
    Company & Industry Overviews

    Wall Street Analysts Are Still Bullish on ALGN Stock

    Align Technology (ALGN) stock hasn’t received any recommendation updates since the stock was upgraded by several analysts in July.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Will Dentsply Sirona Stock Recover from Recent Declines?

    On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share.

    By Sarah Collins
  • uploads///tooth _
    Earnings Report

    Analysts Cut Their Targets for XRAY ahead of Its 1Q18 Results

    Dentsply Sirona, one of the leading dental technology providers in the United States, will announce its 1Q18 earnings results on May 7.

    By Sarah Collins
  • why is algn stock going up
    Earnings Report

    Align Stock Jumps After Q3 Earnings Call

    By Rachel Curry
  • uploads///stock trading monitor desk
    Consumer

    Renaissance Technologies: Analyzing Its Q3 13F

    At the end of the third quarter, Bristol-Myers Squibb, Celgene, Biogen, UnitedHealth, and Walmart (WMT) were Renaissance Technologies’ top five buys.

    By Rabindra Samanta
  • uploads///Align technolgies
    Company & Industry Overviews

    Align Technology Stock Recovers after Tanking Last Week

    Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?

    By Sushree Mohanty
  • uploads///AdobeStock_
    Earnings Report

    Align Technology Disappoints Investors with Reduced Guidance

    Yesterday, Align Technology (ALGN) reported its second-quarter earnings results after the market closed.

    By Margaret Patrick
  • uploads///woman _
    Earnings Report

    Align Technology: What to Expect in Q2

    Align Technology (ALGN) plans to release its second-quarter earnings on July 24 after the market closes.

    By Margaret Patrick
  • uploads///bank _
    Macroeconomic Analysis

    Powell’s Testimony Drives US Stock Market to All-Time High

    This morning, US index futures surged after Federal Reserve Chair Jerome Powell’s testimony raised the possibility of a near-term cut in interest rates.

    By Jitendra Parashar
  • uploads///hospital _
    Company & Industry Overviews

    How These Medical Equipment Stocks Have Fared in the Last Month

    In December 2018, of the total 15 analysts covering Align Technology, 13 analysts have given the stock a “buy” or higher rating.

    By Kenneth Smith
  • uploads///hypertension _
    Company & Industry Overviews

    Taking Stock of Edwards Lifesciences’ Performance

    A strong operational performance and steady uptick in Edwards Lifesciences’ stock price has kept investors interested in the stock in 2018.

    By Kenneth Smith
  • uploads///ISRG
    Company & Industry Overviews

    Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date

    Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.

    By Daniel Collins
  • uploads///XRAY
    Company & Industry Overviews

    What Does Dentsply’s Bottom-Line Trend Indicate?

    Dentsply Sirona’s interest expense decreased marginally from $9.8 million in the third quarter of 2017 to $9.7 million in the third quarter.

    By Kenneth Smith
  • uploads///hospital _
    Company & Industry Overviews

    How Wall Street Analysts View TransEnterix

    Of the five analysts tracking TransEnterix in July, two of them have recommended a “strong buy,” and one has recommended a “buy.”

    By Daniel Collins
  • uploads///paper _
    Company & Industry Overviews

    20 Earnings Reports to Watch for This Week

    Earnings season is in full swing, and the week of April 23 is jam-packed with releases by some of the market’s most popular companies. Here are 20 reports we will be watching closely next week: Monday, April 23: Hasbro, Inc. (NASDAQ: HAS) – before the market opens -will they say anything about Mattel with the […]

    By JP Gravitt
  • uploads///OPERATIONAL EXCELLENCE
    Company & Industry Overviews

    Here’s What Dentsply Sirona Has Planned for Its Margins

    Dentsply Sirona has a new management team that is working toward a more successful integration because it delivered lower-than-expected synergies in 2017.

    By Sarah Collins
  • uploads///NEW SEGMENT STRUCTUR
    Company & Industry Overviews

    Understanding Dentsply Sirona’s New Organizational Structure

    In 4Q17, Dentsply Sirona (XRAY) started reporting its operations under two segments, after a shift to three segments in fiscal 3Q17.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Reading Dentsply Sirona’s Recent Stock Performance

    On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.

    By Sarah Collins
  • uploads///peter kasprzyk  unsplash
    Company & Industry Overviews

    Why Is Wall Street Still Upbeat on Dentsply Sirona’s Growth Potential in 2018?

    Dentsply Sirona is a leading dental technology, equipment, and consumables provider in the US. But it has been going through some tough times.

    By Sarah Collins
  • uploads///SDC
    Company & Industry Overviews

    Align Technology and Its SmileDirectClub Partnership

    In 4Q17, Align Technology reported a sequential decline in its shipments of non-Invisalign SDC aligners to SDC.

    By Sarah Collins
  • uploads///strategic priorities
    Company & Industry Overviews

    Align Technology to Execute on Key Strategic Priorities in 2018

    Align Technology (ALGN) has been growing at a fast pace while it executes its strategic priorities around the world.

    By Sarah Collins
  • uploads///Invisalign shipment trend
    Company & Industry Overviews

    Align Technology’s Invisalign: Average Selling Price and Volumes

    Increases in Align Technology’s (ALGN) Invisalign volumes and ASP were the major factors driving the company’s sales growth.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Align Technology: Analyst Ratings and Recommendations

    Of the 12 investment research firms following ALGN stock, ten of them have given the stock “buy” or “strong buy” recommendations.

    By Sarah Collins
  • uploads///Q_highlights
    Company & Industry Overviews

    Inside Abbott Laboratories’ 4Q17 Earnings Results: Key Highlights

    Abbott Laboratories (ABT) reported sales of $7.6 billion and adjusted diluted EPS (earnings per share) of $0.74 for fiscal 4Q17.

    By Sarah Collins
  • uploads///RECMMENDATIONS
    Company & Industry Overviews

    Wall Street Issues Majority ‘Buy’ Ratings on Align Technology

    On December 29, 2017, according to 12 investment brokerage firms which were part of a Reuters survey, Align Technology stock has received a “buy” rating from 11 analysts.

    By Sarah Collins
  • uploads///value chain
    Company & Industry Overviews

    Align Technology’s Customer Acquisition Strategy Driving Market Growth

    In 3Q17, Align Technology trained nearly 1,000 doctors in China.

    By Sarah Collins
  • uploads///MARKET OPPORTNITY
    Company & Industry Overviews

    Align Technology’s Growth Prospects amid Increasing Competition

    The Chinese market is Align Technology’s major growth driver. However, the company is starting to witness strong competition from startups focused on the clear aligners market.

    By Sarah Collins
  • uploads///REVENUES BY SEGMENT
    Company & Industry Overviews

    Dental and Healthcare Consumables Grew but Missed Expectations in 2Q17

    In 2Q17, Dentsply Sirona’s (XRAY) Dental and Healthcare Consumables business contributed ~56% to the company’s total revenues and registered sales of ~$554 million.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Align Technology Focuses on International Market Strategy

    International market strategy In 2Q17, Align Technology (ALGN) reported 85,400 Invisalign case shipments in international markets, which is YoY (year-over-year) growth of ~37.4% and sequential growth of ~13.6%. This growth was mainly attributed to new customers in the EMEA (Europe, the Middle East, and Africa) and Asia-Pacific markets. If Align Technology continues to demonstrate solid […]

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Market Expansion Strategy

    In 1Q17, Align Technology (ALGN) also witnessed a robust rise of around 45.2% in volumes of Invisalign sold in Asia-Pacific markets on a YoY basis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Understanding Align Technology’s Growing Position in International Markets

    In 1Q17, Align Technology (ALGN) witnessed an 11.4% sequential rise in the volume of Invisalign cases used by doctors in international markets.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    These Are Align Technologies Key Demand Drivers in North America

    In 1Q17, Align Technology (ALGN) has started selling its new product Invisalign Go in North America, which involves a few DSOs (dental service organizations).

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Behind Align Technology’s North American Expectations for 2017

    In 1Q17, Align Technology’s (ALGN) Invisalign sales volumes in North American markets rose YoY by 20.3% and QoQ by 8.3%.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Why Align Technology’s Orthodontics Is a Solid Growth Opportunity in 2017

    Align Technology (ALGN) is a medical device provider focused on malocclusion or teeth misalignment condition.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Inside Align Technology’s Robust Revenue Growth Projection for 2017

    For fiscal 2017, Align Technology (ALGN) expects its 2017 revenues to grow operationally in the range of 15%–25% YoY.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Align Technology versus Peers in June 2017: Analyst Recommendations

    For 1Q17, Align Technology (ALGN) reported revenues close to $310.3 million, which represents YoY (year-over-year) growth of around 30.0%.

    By Margaret Patrick
  • uploads///profitability
    Earnings Report

    How Dentsply Sirona’s Profitability Metrics Looked in 1Q17

    Dentsply Sirona’s (XRAY) 1Q17 earnings and revenue failed to meet analysts’ estimates. The company reported a fall in its organic revenue.

    By Sarah Collins
  • uploads///Healthcare Sector Outperforming Overall Market Since
    Macroeconomic Analysis

    The Larger Aims of Obamacare: An Overview

    The idea behind Obamacare was that it would embody legislation not only providing but mandating healthcare coverage for nearly everyone in the US.

    By Mary Sadler
  • uploads///analyst recommendations
    Healthcare

    What Are Analysts’ Recommendations for Dentsply Sirona?

    According to a Bloomberg survey, 43% of the analysts gave Dentsply Sirona a “buy” rating and ~57% gave it a “hold” rating. It didn’t have any “sell” ratings.

    By Sarah Collins
  • uploads///combined business profile
    Healthcare

    Why Is Dentsply Sirona Acquiring MIS Implants?

    Dentsply Sirona is acquiring MIS due to its established brand and broad portfolio of implants and related products.

    By Sarah Collins
  • uploads///product portfolio
    Company & Industry Overviews

    A Brief Look at Dentsply Sirona’s Business Model

    Dentsply Sirona (XRAY) offers a broad portfolio of dental equipment and consumables that have urological and surgical applications.

    By Sarah Collins
  • uploads///combined business profile
    Company & Industry Overviews

    Introducing Dentsply Sirona, a Leading Dental Products Manufacturer

    Dentsply Sirona (XRAY) is the largest manufacturer of dental equipment and technologies in the world. The company was formed in February 2016.

    By Sarah Collins
  • uploads///siro pm
    Earnings Report

    Analyzing Sirona Dental Systems’ Rise in Revenue in Fiscal 4Q15

    After the release of Sirona Dental Systems’ (SIRO) 4Q15 earnings report, SIRO rose by 0.23% to close at $109.22 per share on November 20, 2015.

    By Gabriel Kane
  • uploads///xray pbv
    Earnings Report

    How Does Dentsply International Compare to Peers after 3Q15?

    In this article, we’ll compare Dentsply against its peers and the ETFs that invest in Dentsply.

    By Gabriel Kane
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.